These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis. Egberts F; Möller M; Proksch E; Schwarz T J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol. Torbahn G; Hofmann H; Allert R; Freitag MH; Dersch R; Fingerle V; Sommer H; Motschall E; Meerpohl JJ; Schmucker C Syst Rev; 2016 May; 5():73. PubMed ID: 27142846 [TBL] [Abstract][Full Text] [Related]
26. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans. Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971 [TBL] [Abstract][Full Text] [Related]
27. Doxycycline suppresses Chlamydia pneumoniae-mediated increases in ongoing immunoglobulin E and interleukin-4 responses by peripheral blood mononuclear cells of patients with allergic asthma. Dzhindzhikhashvili MS; Joks R; Smith-Norowitz T; Durkin HG; Chotikanatis K; Estrella E; Hammerschlag MR; Kohlhoff SA J Antimicrob Chemother; 2013 Oct; 68(10):2363-8. PubMed ID: 23749949 [TBL] [Abstract][Full Text] [Related]
28. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans. Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835 [TBL] [Abstract][Full Text] [Related]
30. An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine. Schoen RT; Deshefy-Longhi T; Van-Hoecke C; Buscarino C; Fikrig E Clin Ther; 2003 Jan; 25(1):210-24. PubMed ID: 12637121 [TBL] [Abstract][Full Text] [Related]
31. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. Nadelman RB; Nowakowski J; Fish D; Falco RC; Freeman K; McKenna D; Welch P; Marcus R; Agüero-Rosenfeld ME; Dennis DT; Wormser GP; N Engl J Med; 2001 Jul; 345(2):79-84. PubMed ID: 11450675 [TBL] [Abstract][Full Text] [Related]
32. What we have learned about Lyme borreliosis from studies in children. Sood SK Wien Klin Wochenschr; 2006 Nov; 118(21-22):638-42. PubMed ID: 17160601 [TBL] [Abstract][Full Text] [Related]
33. Summaries for patients. Duration of antibiotic treatment for early Lyme disease. Ann Intern Med; 2003 May; 138(9):I27. PubMed ID: 12729446 [No Abstract] [Full Text] [Related]
34. [Bactericidal properties of neutrophils from peripheral blood (PMN)of patients with Lyme borreliosis]. Izycka A; Jabłońska E; Zajkowska J; Hermanowska-Szpakowicz T; Izycki T; Piecuch J; Pancewicz S Med Dosw Mikrobiol; 2000; 52(2):165-71. PubMed ID: 11107790 [TBL] [Abstract][Full Text] [Related]
35. [Protective activity of Immunovac-VP-4 vaccine against avian influenza virus H5N2 administered by different methods]. Egorova NB; Kurbatova EA; Akhmatova NK; Semenova IB Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):49-53. PubMed ID: 21446167 [TBL] [Abstract][Full Text] [Related]
36. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Codolo G; Amedei A; Steere AC; Papinutto E; Cappon A; Polenghi A; Benagiano M; Paccani SR; Sambri V; Del Prete G; Baldari CT; Zanotti G; Montecucco C; D'Elios MM; de Bernard M Arthritis Rheum; 2008 Nov; 58(11):3609-17. PubMed ID: 18975343 [TBL] [Abstract][Full Text] [Related]
37. Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro. Bode C; Diedrich B; Muenster S; Hentschel V; Weisheit C; Rommelsheim K; Hoeft A; Meyer R; Boehm O; Knuefermann P; Baumgarten G Int Immunopharmacol; 2014 Jan; 18(1):27-34. PubMed ID: 24239744 [TBL] [Abstract][Full Text] [Related]
38. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202 [TBL] [Abstract][Full Text] [Related]
39. [Effect of aluminium hydroxide on innate immunity and immunogenicity of bacterial and synthetic antigens of Streptococcus pneumoniae]. Kurbatova EA; Akhmatov ÉA; Akhmatova NK; Vorob'ev DS; Egorova NB; Baturo AP; Romanenko ÉE; Tsvetkov IuE; Sukhova EV; Iashunskiĭ DV; Nifant'ev NÉ Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):59-67. PubMed ID: 25816515 [TBL] [Abstract][Full Text] [Related]
40. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. Gerber MA; Shapiro ED; Burke GS; Parcells VJ; Bell GL N Engl J Med; 1996 Oct; 335(17):1270-4. PubMed ID: 8857006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]